| Publication Number | Title | Priority Date |
|---|---|---|
| CN-112266386-A | 2-chloroadenine derivative, preparation method and application | 2020-10-20 |
| WO-2022053967-A1 | Heterocyclic compounds as cbp/ep300 bromodomain inhibitors | 2020-09-09 |
| WO-2022048684-A1 | Jnk inhibitor, pharmaceutical composition thereof and use thereof | 2020-09-07 |
| WO-2022025174-A1 | Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof | 2020-07-30 |
| US-2022033398-A1 | Fused bicyclic raf inhibitors and methods for use thereof | 2020-07-28 |
| WO-2022023447-A2 | Fused bicyclic raf inhibitors and methods for use thereof | 2020-07-28 |
| WO-2022017338-A1 | Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same | 2020-07-20 |
| CN-113943278-A | Immunomodulator | 2020-07-16 |
| CN-113896744-A | Selective EGFR inhibitor | 2020-07-06 |
| WO-2022006543-A1 | 5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases | 2020-07-02 |
